Here, we report that inhibition of APE1/Ref-1 redox signaling activity decreases prostate cancer cell proliferation, decreases the transcriptional activity of NFκB, and downregulates survivin expression in prostate cancer cells in vitro and in vivo. The gene discussed is BIRC5; the disease is prostate cancer.